<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The arylamine N-acetyltransferase 2 (NAT2) enzymes detoxify a wide range of naturally occurring <z:chebi fb="0" ids="35703">xenobiotics</z:chebi> including carcinogens and drugs </plain></SENT>
<SENT sid="1" pm="."><plain>Point mutations in the NAT2 gene result in the variant alleles M1 (NAT2 *5A), M2 (NAT2*6A), M3 (NAT2*7) and M4 (NAT2 *14A) from the <z:mp ids='MP_0002169'>wild-type</z:mp> WT (NAT2 *4) allele </plain></SENT>
<SENT sid="2" pm="."><plain>The current study was aimed at screening genetic polymorphisms of NAT2 gene in 49 lung <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, 54 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and 99 cancer-free controls, using PCR-RFLP </plain></SENT>
<SENT sid="3" pm="."><plain>There were significant differences in allele frequencies between <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> patients and controls in the WT, M2 and M3 alleles (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>However, only M2 and M3 allele frequencies were different between <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and controls (p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>There was a marginal significant difference in the distribution of rapid and slow acetylator genotypes between <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> patients and controls (p = 0.06 and p = 0.05, respectively), but not between <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and controls (p = 1.0 and p = 0.95, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Risk of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> development was found to be lower in slow acetylators [odds ratio (OR): 0.51, 95% confidence interval (95% CI): 0.25, 1.02, p-value = 0.07] </plain></SENT>
<SENT sid="7" pm="."><plain>No effect was observed in case of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Our results showed that NAT2 genotypes and phenotypes might be involved in <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> but not <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> susceptibility in Jordan </plain></SENT>
</text></document>